Report cover image

Point-of-Care Molecular Diagnostics Market by Product & Service (Assays, Instruments, Software), Technology (RT-PCR, INAAT), Sample Type (Blood, Urine), Application (STD, HAI, Hepatitis, Cancer), and End User (Hospitals, Clinics) - Global Forecast to 2030

Publisher MarketsandMarkets
Published Sep 03, 2025
Length 328 Pages
SKU # MKMK20389294

Description

The global point-of-care molecular diagnostics market is projected to reach USD 7.09 billion by 2030, from USD 4.30 billion in 2025, with a CAGR of 10.5%. The market is primarily driven by the increasing focus on decentralized testing, which facilitates faster clinical decisions across various care settings. This is especially crucial in resource-limited or remote areas where timely decision-making is vital. Rising R&D investments are further supporting the development of advanced, portable technologies that make molecular testing easier while maintaining reliability. These innovations are helping healthcare providers adopt point-of-care solutions outside traditional laboratory settings.

Assays & kits accounted for the highest growth rate in the point-of-care molecular diagnostics market by product & service.

The point-of-care molecular diagnostics market is classified into assays & kits, instruments & analyzers, and software & services. Assays & kits are expected to be the fastest-growing segment during the forecast period. This growth is fueled by the rising need for quick and precise testing solutions that can be used directly at the point of care. The frequent use and ongoing demand for assay kits across various clinical settings, as well as their growing role in diagnosing diverse conditions, are key factors supporting this trend. As healthcare systems continue to prioritize early detection and decentralized testing, the demand for reliable and easy-to-use molecular assay kits is likely to increase steadily.

Blood is the fastest-growing segment in the point-of-care molecular diagnostics market by sample type.

The point-of-care molecular diagnostics market includes various sample types, such as blood, urine, and others. The blood sample is expected to experience the highest CAGR during the forecast period, driven by its broad use across different diseases and the availability of minimally invasive collection methods. Blood-based molecular tests provide high sensitivity and specificity, making them suitable for detecting a wide range of infectious diseases, including HIV, hepatitis, and sepsis. The increasing demand for rapid diagnostics in critical care settings, where blood is often the preferred sample, further supports this growth. Additionally, technological advancements have improved the efficiency and reliability of blood-based point-of-care testing, promoting its wider adoption.

Asia Pacific exhibits the fastest growth in the point-of-care molecular diagnostics market.

The global market for point-of-care molecular diagnostics is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to experience the fastest growth in this market. This expansion is fueled by increasing healthcare spending, broader access to diagnostic services, and more government efforts to improve early disease detection. Additionally, ongoing investments in healthcare infrastructure and rising awareness of the benefits of point-of-care testing create positive conditions for market growth. The presence of emerging economies like China and India further boosts growth prospects due to their growing focus on enhancing diagnostic capabilities.

The break-up of the profile of primary participants in the point-of-care molecular diagnostics market:
  • By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
  • By Designation: C-level – 27%, D-level – 18%, and Others – 55%
  • By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa – 4%
The key players in this market are Danaher Corporation (US), bioMérieux (France), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), QIAGEN N.V. (Netherlands), QuidelOrtho Corporation (US), Co-Diagnostics, Inc. (US), Biocartis Group NV (Belgium), SD Biosensor, INC. (South Korea), genedrive plc (UK), Binx Health, Inc. (US), Molbio Diagnostics Pvt. Ltd. (India), Genomadix (Canada), Visby Medical, Inc. (US), QuantuMDx Group Ltd. (UK), DetectaChem (US), Labsystems Diagnostics Oy (Finland), Akonni Biosystems, Inc. (US), Ubiquitome Limited (New Zealand), Credo Diagnostics Biomedical Pte. Ltd. (Singapore), OpGen, Inc. (US), Nuclein, LLC (US), Genes2Me (India), Axxin (Australia), and Huwel Lifesciences (India).

Research Coverage:

This report categorizes the point-of-care molecular diagnostics market by product & service (assay & kits, instruments & analyzers, and software & services), technology (RT-PCR, INAAT, other technologies), sample type (blood samples, urine, and other sample types), application (respiratory diseases, sexually transmitted diseases, hospital-acquired infections, cancer, hepatitis, gastrointestinal disorders, and other applications), end user (physicians’ offices/clinics, hospitals, research institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report includes detailed information about the major factors affecting the growth of the point-of-care molecular diagnostics market, such as drivers, restraints, opportunities, and challenges. A thorough analysis of key industry players has been conducted to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. The report also covers new product launches and recent developments related to the point-of-care molecular diagnostics market. Additionally, it includes a competitive analysis of upcoming startups within the point-of-care molecular diagnostics market ecosystem.

Reasons to buy this report:

The report will assist market leaders and new entrants by providing near-accurate estimates of the revenue for the overall point-of-care molecular diagnostics market and its subsegments. It will help stakeholders understand the competitive landscape and gain insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report offers stakeholders an understanding of market dynamics, including key drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:
  • Analysis of key drivers (rising incidence of infectious diseases and cancer, increasing focus on decentralized diagnostics, improved awareness of early detection of infectious diseases), opportunities (untapped growth potential across emerging economies), restraints (unfavorable reimbursement scenario, substantial initial investment and low cost-benefit ratio), and challenges (stringent and time-consuming regulatory policies, emergence of alternative technologies) influencing the growth of the point-of-care molecular diagnostics market
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the point-of-care molecular diagnostics market
  • Market Development: Comprehensive information about lucrative markets – the report analyses the point-of-care molecular diagnostics market across varied regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the point-of-care molecular diagnostics market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Danaher Corporation (US), bioMérieux (France), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), and QIAGEN N.V. (Netherlands)
Tables List
Table 1 Point Of Care Molecular Diagnostics Market: Inclusions & Exclusions
Table 2 Point Of Care Molecular Diagnostics Market:
Key Data From Primary Sources
Table 3 Point Of Care Molecular Diagnostics Market: Risk Assessment Analysis
Table 4 Regional Hiv Data, 2024
Table 5 Average Selling Pricing Trend Of Point Of Care Molecular Diagnostic Products, 2023–2025
Table 6 Average Selling Price Trend Of Point Of Care Molecular
Diagnostic Assays & Kits, By Key Player, 2023–2025
Table 7 Average Selling Price Trend Of Point Of Care Molecular
Diagnostic Products, By Region, 2023–2025
Table 8 Point Of Care Molecular Diagnostics Market: List Of Major Patents
Table 9 Import Data For Diagnostic And Laboratory Reagents (Hs Code 3822), By Country, 2020–2024 (Usd Million)
Table 10 Export Data For Diagnostic And Laboratory Reagents (Hs Code 3822), By Country, 2020–2024 (Usd Million)
Table 11 Point Of Care Molecular Diagnostics Market: Role In Ecosystem
Table 12 Point Of Care Molecular Diagnostics Market:
Porter’s Five Forces Analysis
Table 13 Classification Of Ivd Devices In Europe
Table 14 Time, Cost, And Complexity Of Registration Process In Japan
Table 17 Asia Pacific: Key Regulatory Bodies, Government Agencies,
And Other Organizations
Table 20 Point Of Care Molecular Diagnostics Market: Detailed List
Of Key Conferences & Events, January 2025–december 2026
Table 21 Influence Of Stakeholders On Buying Process Of Point Of Care Molecular Diagnostic Products (%)
Table 22 Key Buying Criteria For Point Of Care Molecular Diagnostic Products
Table 23 Implementation Of Ai, By Key Company & Use Case
Table 24 Us-adjusted Reciprocal Tariff Rates
Table 25 Point Of Care Molecular Diagnostics Market, By Product &
Service, 2023–2030 (Usd Million)
Table 26 Key Assays & Kits Currently Available
Table 27 Point Of Care Molecular Diagnostics Market For Assays & Kits,
By Region, 2023–2030 (Usd Million)
Table 28 North America: Point Of Care Molecular Diagnostics Market
For Assays & Kits, By Country, 2023–2030 (Usd Million)
Table 29 Europe: Point Of Care Molecular Diagnostics Market For Assays &
Kits, By Country, 2023–2030 (Usd Million)
Table 30 Asia Pacific: Point Of Care Molecular Diagnostics Market For Assays & Kits, By Country, 2023–2030 (Usd Million)
Table 31 Latin America: Point Of Care Molecular Diagnostics Market For Assays & Kits, By Country, 2023–2030 (Usd Million)
Table 32 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Assays & Kits, By Country, 2023–2030 (Usd Million)
Table 33 Key Instruments & Analyzers Currently Available
Table 34 Point Of Care Molecular Diagnostics Market For Instruments & Analyzers, By Region, 2023–2030 (Usd Million)
Table 35 North America: Point Of Care Molecular Diagnostics Market For Instruments & Analyzers, By Country, 2023–2030 (Usd Million)
Table 36 Europe: Point Of Care Molecular Diagnostics Market For Instruments & Analyzers, By Country, 2023–2030 (Usd Million)
Table 37 Asia Pacific: Point Of Care Molecular Diagnostics Market For Instruments & Analyzers, By Country, 2023–2030 (Usd Million)
Table 38 Latin America: Point Of Care Molecular Diagnostics Market For Instruments & Analyzers, By Country, 2023–2030 (Usd Million)
Table 39 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Instruments & Analyzers, By Country, 2023–2030 (Usd Million)
Table 40 Key Software & Services Currently Available
Table 41 Point Of Care Molecular Diagnostics Market For Software & Services, By Region, 2023–2030 (Usd Million)
Table 42 North America: Point Of Care Molecular Diagnostics Market For Software & Services, By Country, 2023–2030 (Usd Million)
Table 43 Europe: Point Of Care Molecular Diagnostics Market For Software & Services, By Country, 2023–2030 (Usd Million)
Table 44 Asia Pacific: Point Of Care Molecular Diagnostics Market For Software & Services, By Country, 2023–2030 (Usd Million)
Table 45 Latin America: Point Of Care Molecular Diagnostics Market For Software & Services, By Country, 2023–2030 (Usd Million)
Table 46 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Software & Services, By Country, 2023–2030 (Usd Million)
Table 47 Point Of Care Molecular Diagnostics Market, By Technology,
2023–2030 (Usd Million)
Table 48 Key Rt-pcr-based Products Currently Available
Table 49 Point Of Care Molecular Diagnostics Market For Rt-pcr, By Region, 2023–2030 (Usd Million)
Table 50 North America: Point Of Care Molecular Diagnostics Market For
Rt-pcr, By Country, 2023–2030 (Usd Million)
Table 51 Europe: Point Of Care Molecular Diagnostics Market For Rt-pcr,
By Country, 2023–2030 (Usd Million)
Table 52 Asia Pacific: Point Of Care Molecular Diagnostics Market For Rt-pcr,
By Country, 2023–2030 (Usd Million)
Table 53 Latin America: Point Of Care Molecular Diagnostics Market For
Rt-pcr, By Country, 2023–2030 (Usd Million)
Table 54 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Rt-pcr, By Country, 2023–2030 (Usd Million)
Table 55 Key Inaat-based Products Currently Available
Table 56 Point Of Care Molecular Diagnostics Market For Inaat, By Region, 2023–2030 (Usd Million)
Table 57 North America: Point Of Care Molecular Diagnostics Market For Inaat, By Country, 2023–2030 (Usd Million)
Table 58 Europe: Point Of Care Molecular Diagnostics Market For Inaat,
By Country, 2023–2030 (Usd Million)
Table 59 Asia Pacific: Point Of Care Molecular Diagnostics Market For Inaat,
By Country, 2023–2030 (Usd Million)
Table 60 Latin America: Point Of Care Molecular Diagnostics Market For
Inaat, By Country, 2023–2030 (Usd Million)
Table 61 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Inaat, By Country, 2023–2030 (Usd Million)
Table 62 Point Of Care Molecular Diagnostics Market For Other Technologies, By Region, 2023–2030 (Usd Million)
Table 63 North America: Point Of Care Molecular Diagnostics Market For
Other Technologies, By Country, 2023–2030 (Usd Million)
Table 64 Europe: Point Of Care Molecular Diagnostics Market
For Other Technologies, By Country, 2023–2030 (Usd Million)
Table 65 Asia Pacific: Point Of Care Molecular Diagnostics Market
For Other Technologies, By Country, 2023–2030 (Usd Million)
Table 66 Latin America: Point Of Care Molecular Diagnostics Market
For Other Technologies, By Country, 2023–2030 (Usd Million)
Table 67 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Other Technologies, By Country, 2023–2030 (Usd Million)
Table 68 Point Of Care Molecular Diagnostics Market, By Sample Type,
2023–2030 (Usd Million)
Table 69 Key Blood Sample Type-based Products Currently Available
Table 70 Point Of Care Molecular Diagnostics Market For Blood Samples,
By Region, 2023–2030 (Usd Million)
Table 71 North America: Point Of Care Molecular Diagnostics Market For
Blood Samples, By Country, 2023–2030 (Usd Million)
Table 72 Europe: Point Of Care Molecular Diagnostics Market For
Blood Samples, By Country, 2023–2030 (Usd Million)
Table 73 Asia Pacific: Point Of Care Molecular Diagnostics Market For
Blood Samples, By Country, 2023–2030 (Usd Million)
Table 74 Latin America: Point Of Care Molecular Diagnostics Market For
Blood Samples, By Country, 2023–2030 (Usd Million)
Table 75 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Blood Samples, By Country, 2023–2030 (Usd Million)
Table 76 Key Urine Sample-based Products Currently Available
Table 77 Point Of Care Molecular Diagnostics Market For Urine Samples,
By Region, 2023–2030 (Usd Million)
Table 78 North America: Point Of Care Molecular Diagnostics Market For Urine Samples, By Country, 2023–2030 (Usd Million)
Table 79 Europe: Point Of Care Molecular Diagnostics Market For Urine Samples, By Country, 2023–2030 (Usd Million)
Table 80 Asia Pacific: Point Of Care Molecular Diagnostics Market For Urine Samples, By Country, 2023–2030 (Usd Million)
Table 81 Latin America: Point Of Care Molecular Diagnostics Market For Urine Samples, By Country, 2023–2030 (Usd Million)
Table 82 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Urine Samples, By Country, 2023–2030 (Usd Million)
Table 83 Key Other Sample Type-based Products Currently Available
Table 84 Point Of Care Molecular Diagnostics Market For Other Sample Types, By Region, 2023–2030 (Usd Million)
Table 85 North America: Point Of Care Molecular Diagnostics Market For
Other Sample Types, By Country, 2023–2030 (Usd Million)
Table 86 Europe: Point Of Care Molecular Diagnostics Market For Other
Sample Types, By Country, 2023–2030 (Usd Million)
Table 87 Asia Pacific: Point Of Care Molecular Diagnostics Market For
Other Sample Types, By Country, 2023–2030 (Usd Million)
Table 88 Latin America: Point Of Care Molecular Diagnostics Market For
Other Sample Types, By Country, 2023–2030 (Usd Million)
Table 89 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Other Sample Types, By Country, 2023–2030 (Usd Million)
Table 90 Point Of Care Molecular Diagnostics Market, By Application,
2023–2030 (Usd Million)
Table 91 Key Poc Molecular Diagnostic Products For Respiratory
Diseases Currently Available
Table 92 Point Of Care Molecular Diagnostics Market For Respiratory
Diseases, By Region, 2023–2030 (Usd Million)
Table 93 North America: Point Of Care Molecular Diagnostics Market For Respiratory Diseases, By Country, 2023–2030 (Usd Million)
Table 94 Europe: Point Of Care Molecular Diagnostics Market For Respiratory Diseases, By Country, 2023–2030 (Usd Million)
Table 95 Asia Pacific: Point Of Care Molecular Diagnostics Market For Respiratory Diseases, By Country, 2023–2030 (Usd Million)
Table 96 Latin America: Point Of Care Molecular Diagnostics Market For Respiratory Diseases, By Country, 2023–2030 (Usd Million)
Table 97 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Respiratory Diseases, By Country, 2023–2030 (Usd Million)
Table 98 Number Of Newly Diagnosed Tuberculosis (Tb) Cases,
2023–2030 (In Millions)
Table 99 Key Poc Molecular Diagnostic Products For Sexually Transmitted Diseases Currently Available
Table 100 Point Of Care Molecular Diagnostics Market For Sexually Transmitted Diseases, By Region, 2023–2030 (Usd Million)
Table 101 North America: Point Of Care Molecular Diagnostics Market For Sexually Transmitted Diseases, By Country, 2023–2030 (Usd Million)
Table 102 Europe: Point Of Care Molecular Diagnostics Market For Sexually Transmitted Diseases, By Country, 2023–2030 (Usd Million)
Table 103 Asia Pacific: Point Of Care Molecular Diagnostics Market For Sexually Transmitted Diseases, By Country, 2023–2030 (Usd Million)
Table 104 Latin America: Point Of Care Molecular Diagnostics Market For Sexually Transmitted Diseases, By Country, 2023–2030 (Usd Million)
Table 105 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Sexually Transmitted Diseases, By Country, 2023–2030 (Usd Million)
Table 106 Point Of Care Molecular Diagnostics Market For Hospital-acquired Infections, By Region, 2023–2030 (Usd Million)
Table 107 North America: Point Of Care Molecular Diagnostics Market For Hospital-acquired Infections, By Country, 2023–2030 (Usd Million)
Table 108 Europe: Point Of Care Molecular Diagnostics Market For Hospital-acquired Infections, By Country, 2023–2030 (Usd Million)
Table 109 Asia Pacific: Point Of Care Molecular Diagnostics Market For Hospital-acquired Infections, By Country, 2023–2030 (Usd Million)
Table 110 Latin America: Point Of Care Molecular Diagnostics Market For Hospital-acquired Infections, By Country, 2023–2030 (Usd Million)
Table 111 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Hospital-acquired Infections, By Country, 2023–2030 (Usd Million)
Table 112 Point Of Care Molecular Diagnostics Market For Cancer, By Region, 2023–2030 (Usd Million)
Table 113 North America: Point Of Care Molecular Diagnostics Market For Cancer, By Country, 2023–2030 (Usd Million)
Table 114 Europe: Point Of Care Molecular Diagnostics Market For Cancer,
By Country, 2023–2030 (Usd Million)
Table 115 Asia Pacific: Point Of Care Molecular Diagnostics Market For Cancer, By Country, 2023–2030 (Usd Million)
Table 116 Latin America: Point Of Care Molecular Diagnostics Market For Cancer, By Country, 2023–2030 (Usd Million)
Table 117 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Cancer, By Country, 2023–2030 (Usd Million)
Table 118 Key Poc Molecular Diagnostic Products For Hepatitis
Currently Available
Table 119 Point Of Care Molecular Diagnostics Market For Hepatitis, By Region, 2023–2030 (Usd Million)
Table 120 North America: Point Of Care Molecular Diagnostics Market For Hepatitis, By Country, 2023–2030 (Usd Million)
Table 121 Europe: Point Of Care Molecular Diagnostics Market For Hepatitis,
By Country, 2023–2030 (Usd Million)
Table 122 Asia Pacific: Point Of Care Molecular Diagnostics Market For Hepatitis, By Country, 2023–2030 (Usd Million)
Table 123 Latin America: Point Of Care Molecular Diagnostics Market For Hepatitis, By Country, 2023–2030 (Usd Million)
Table 124 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Hepatitis, By Country, 2023–2030 (Usd Million)
Table 125 Key Poc Molecular Diagnostic Products For Gastrointestinal Disorders Currently Available
Table 126 Point Of Care Molecular Diagnostics Market For Gastrointestinal Disorders, By Region, 2023–2030 (Usd Million)
Table 127 North America: Point Of Care Molecular Diagnostics Market For Gastrointestinal Disorders, By Country, 2023–2030 (Usd Million)
Table 128 Europe: Point Of Care Molecular Diagnostics Market For Gastrointestinal Disorders, By Country, 2023–2030 (Usd Million)
Table 129 Asia Pacific: Point Of Care Molecular Diagnostics Market For Gastrointestinal Disorders, By Country, 2023–2030 (Usd Million)
Table 130 Latin America: Point Of Care Molecular Diagnostics Market For Gastrointestinal Disorders, By Country, 2023–2030 (Usd Million)
Table 131 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Gastrointestinal Disorders, By Country, 2023–2030 (Usd Million)
Table 132 Key Poc Molecular Diagnostic Products For Other Applications Currently Available
Table 133 Point Of Care Molecular Diagnostics Market For Other Applications, By Region, 2023–2030 (Usd Million)
Table 134 North America: Point Of Care Molecular Diagnostics Market For
Other Applications, By Country, 2023–2030 (Usd Million)
Table 135 Europe: Point Of Care Molecular Diagnostics Market For Other Applications, By Country, 2023–2030 (Usd Million)
Table 136 Asia Pacific: Point Of Care Molecular Diagnostics Market For Other Applications, By Country, 2023–2030 (Usd Million)
Table 137 Latin America: Point Of Care Molecular Diagnostics Market For Other Applications, By Country, 2023–2030 (Usd Million)
Table 138 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Other Applications, By Country, 2023–2030 (Usd Million)
Table 139 Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 140 Point Of Care Molecular Diagnostics Market For Hospitals, By Region, 2023–2030 (Usd Million)
Table 141 Point Of Care Molecular Diagnostics Market For Hospitals, By Disease Type, 2023–2030 (Usd Million)
Table 142 North America: Point Of Care Molecular Diagnostics Market For Hospitals, By Country, 2023–2030 (Usd Million)
Table 143 Europe: Point Of Care Molecular Diagnostics Market For Hospitals,
By Country, 2023–2030 (Usd Million)
Table 144 Asia Pacific: Point Of Care Molecular Diagnostics Market For Hospitals, By Country, 2023–2030 (Usd Million)
Table 145 Latin America: Point Of Care Molecular Diagnostics Market For Hospitals, By Country, 2023–2030 (Usd Million)
Table 146 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Hospitals, By Country, 2023–2030 (Usd Million)
Table 147 Point Of Care Molecular Diagnostics Market For Physicians’ Offices/Clinics, By Region, 2023–2030 (Usd Million)
Table 148 North America: Point Of Care Molecular Diagnostics Market For Physicians’ Offices/Clinics, By Country, 2023–2030 (Usd Million)
Table 149 Europe: Point Of Care Molecular Diagnostics Market For Physicians’ Offices/Clinics, By Country, 2023–2030 (Usd Million)
Table 150 Asia Pacific: Point Of Care Molecular Diagnostics Market For Physicians’ Offices/Clinics, By Country, 2023–2030 (Usd Million)
Table 151 Latin America: Point Of Care Molecular Diagnostics Market For Physicians’ Offices/Clinics, By Country, 2023–2030 (Usd Million)
Table 152 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Physicians’ Offices/Clinics, By Country, 2023–2030 (Usd Million)
Table 153 Point Of Care Molecular Diagnostics Market For Research Institutes, By Region, 2023–2030 (Usd Million)
Table 154 North America: Point Of Care Molecular Diagnostics Market For Research Institutes, By Country, 2023–2030 (Usd Million)
Table 155 Europe: Point Of Care Molecular Diagnostics Market For Research Institutes, By Country, 2023–2030 (Usd Million)
Table 156 Asia Pacific: Point Of Care Molecular Diagnostics Market For Research Institutes, By Country, 2023–2030 (Usd Million)
Table 157 Latin America: Point Of Care Molecular Diagnostics Market For Research Institutes, By Country, 2023–2030 (Usd Million)
Table 158 Middle East & Africa: Point Of Care Molecular Diagnostics Market For Research Institutes, By Country, 2023–2030 (Usd Million)
Table 159 Point Of Care Molecular Diagnostics Market For Other End Users,
By Region, 2023–2030 (Usd Million)
Table 160 North America: Point Of Care Molecular Diagnostics Market For
Other End Users, By Country, 2023–2030 (Usd Million)
Table 161 Europe: Point Of Care Molecular Diagnostics Market For
Other End Users, By Country, 2023–2030 (Usd Million)
Table 162 Asia Pacific: Point Of Care Molecular Diagnostics Market For
Other End Users, By Country, 2023–2030 (Usd Million)
Table 163 Latin America: Point Of Care Molecular Diagnostics Market For
Other End Users, By Country, 2023–2030 (Usd Million)
Table 164 Middle East & Africa: Point Of Care Molecular Diagnostics Market
For Other End Users, By Country, 2023–2030 (Usd Million)
Table 165 Point Of Care Molecular Diagnostics Market, By Region,
2023–2030 (Usd Million)
Table 166 North America: Macroeconomic Indicators
Table 167 North America: Point Of Care Molecular Diagnostics Market,
By Country, 2023–2030 (Usd Million)
Table 168 North America: Point Of Care Molecular Diagnostics Market,
By Product & Service, 2023–2030 (Usd Million)
Table 169 North America: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 170 North America: Point Of Care Molecular Diagnostics Market,
By Sample Type, 2023–2030 (Usd Million)
Table 171 North America: Point Of Care Molecular Diagnostics Market,
By Application, 2023–2030 (Usd Million)
Table 172 North America: Point Of Care Molecular Diagnostics Market,
By End User, 2023–2030 (Usd Million)
Table 173 Us: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 174 Us: Point Of Care Molecular Diagnostics Market, By Technology,
2023–2030 (Usd Million)
Table 175 Us: Point Of Care Molecular Diagnostics Market, By Sample Type,
2023–2030 (Usd Million)
Table 176 Us: Point Of Care Molecular Diagnostics Market, By Application,
2023–2030 (Usd Million)
Table 177 Us: Point Of Care Molecular Diagnostics Market, By End User,
2023–2030 (Usd Million)
Table 178 Canada: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 179 Canada: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 180 Canada: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 181 Canada: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 182 Canada: Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 183 Europe: Macroeconomic Indicators
Table 184 Europe: Point Of Care Molecular Diagnostics Market, By Country, 2023–2030 (Usd Million)
Table 185 Europe: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 186 Europe: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 187 Europe: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 188 Europe: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 189 Europe: Point Of Care Molecular Diagnostics Market,
By End User, 2023–2030 (Usd Million)
Table 190 Germany: Point Of Care Molecular Diagnostics Market,
By Product & Service, 2023–2030 (Usd Million)
Table 191 Germany: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 192 Germany: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 193 Germany: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 194 Germany: Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 195 Uk: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 196 Uk: Point Of Care Molecular Diagnostics Market, By Technology,
2023–2030 (Usd Million)
Table 197 Uk: Point Of Care Molecular Diagnostics Market, By Sample Type,
2023–2030 (Usd Million)
Table 198 Uk: Point Of Care Molecular Diagnostics Market, By Application,
2023–2030 (Usd Million)
Table 199 Uk: Point Of Care Molecular Diagnostics Market, By End User,
2023–2030 (Usd Million)
Table 200 France: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 201 France: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 202 France: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 203 France: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 204 France: Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 205 Italy: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 206 Italy: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 207 Italy: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 208 Italy: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 209 Italy: Point Of Care Molecular Diagnostics Market, By End User,
2023–2030 (Usd Million)
Table 210 Spain: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 211 Spain: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 212 Spain: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 213 Spain: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 214 Spain: Point Of Care Molecular Diagnostics Market, By End User,
2023–2030 (Usd Million)
Table 215 Rest Of Europe: Point Of Care Molecular Diagnostics Market,
By Product & Service, 2023–2030 (Usd Million)
Table 216 Rest Of Europe: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 217 Rest Of Europe: Point Of Care Molecular Diagnostics Market,
By Sample Type, 2023–2030 (Usd Million)
Table 218 Rest Of Europe: Point Of Care Molecular Diagnostics Market,
By Application, 2023–2030 (Usd Million)
Table 219 Rest Of Europe: Point Of Care Molecular Diagnostics Market,
By End User, 2023–2030 (Usd Million)
Table 220 Asia Pacific: Macroeconomic Indicators
Table 221 Asia Pacific: Point Of Care Molecular Diagnostics Market, By Country, 2023–2030 (Usd Million)
Table 222 Asia Pacific: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 223 Asia Pacific: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 224 Asia Pacific: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 225 Asia Pacific: Point Of Care Molecular Diagnostics Market,
By Application, 2023–2030 (Usd Million)
Table 226 Asia Pacific: Point Of Care Molecular Diagnostics Market,
By End User, 2023–2030 (Usd Million)
Table 227 China: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 228 China: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 229 China: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 230 China: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 231 China: Point Of Care Molecular Diagnostics Market, By End User,
2023–2030 (Usd Million)
Table 232 Japan: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 233 Japan: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 234 Japan: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 235 Japan: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 236 Japan: Point Of Care Molecular Diagnostics Market, By End User,
2023–2030 (Usd Million)
Table 237 India: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 238 India: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 239 India: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 240 India: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 241 India: Point Of Care Molecular Diagnostics Market, By End User,
2023–2030 (Usd Million)
Table 242 Rest Of Asia Pacific: Point Of Care Molecular Diagnostics Market,
By Product & Service, 2023–2030 (Usd Million)
Table 243 Rest Of Asia Pacific: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 244 Rest Of Asia Pacific: Point Of Care Molecular Diagnostics Market,
By Sample Type, 2023–2030 (Usd Million)
Table 245 Rest Of Asia Pacific: Point Of Care Molecular Diagnostics Market,
By Application, 2023–2030 (Usd Million)
Table 246 Rest Of Asia Pacific: Point Of Care Molecular Diagnostics Market,
By End User, 2023–2030 (Usd Million)
Table 247 Latin America: Macroeconomic Indicators
Table 248 Latin America: Point Of Care Molecular Diagnostics Market,
By Country, 2023–2030 (Usd Million)
Table 249 Latin America: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 250 Latin America: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 251 Latin America: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 252 Latin America: Point Of Care Molecular Diagnostics Market,
By Application, 2023–2030 (Usd Million)
Table 253 Latin America: Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 254 Brazil: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 255 Brazil: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 256 Brazil: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 257 Brazil: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 258 Brazil: Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 259 Mexico: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 260 Mexico: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 261 Mexico: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 262 Mexico: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 263 Mexico: Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 264 Rest Of Latin America: Point Of Care Molecular Diagnostics Market,
By Product & Service, 2023–2030 (Usd Million)
Table 265 Rest Of Latin America: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 266 Rest Of Latin America: Point Of Care Molecular Diagnostics Market,
By Sample Type, 2023–2030 (Usd Million)
Table 267 Rest Of Latin America: Point Of Care Molecular Diagnostics Market,
By Application, 2023–2030 (Usd Million)
Table 268 Rest Of Latin America: Point Of Care Molecular Diagnostics Market,
By End User, 2023–2030 (Usd Million)
Table 269 Middle East & Africa: Macroeconomic Indicators
Table 270 Middle East & Africa: Point Of Care Molecular Diagnostics Market,
By Country, 2023–2030 (Usd Million)
Table 271 Middle East & Africa: Point Of Care Molecular Diagnostics Market,
By Product & Service, 2023–2030 (Usd Million)
Table 272 Middle East & Africa: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 273 Middle East & Africa: Point Of Care Molecular Diagnostics Market,
By Sample Type, 2023–2030 (Usd Million)
Table 274 Middle East & Africa: Point Of Care Molecular Diagnostics Market,
By Application, 2023–2030 (Usd Million)
Table 275 Middle East & Africa: Point Of Care Molecular Diagnostics Market,
By End User, 2023–2030 (Usd Million)
Table 276 Kingdom Of Saudi Arabia: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 277 Kingdom Of Saudi Arabia: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 278 Ki ngdom Of Saudi Arabia: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 279 Kingdom Of Saudi Arabia: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 280 Kingdom Of Saudi Arabia: Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 281 United Arab Emirates: Point Of Care Molecular Diagnostics Market,
By Product & Service, 2023–2030 (Usd Million)
Table 282 United Arab Emirates: Point Of Care Molecular Diagnostics Market,
By Technology, 2023–2030 (Usd Million)
Table 283 United Arab Emirates: Point Of Care Molecular Diagnostics Market,
By Sample Type, 2023–2030 (Usd Million)
Table 284 United Arab Emirates: Point Of Care Molecular Diagnostics Market,
By Application, 2023–2030 (Usd Million)
Table 285 United Arab Emirates: Point Of Care Molecular Diagnostics Market,
By End User, 2023–2030 (Usd Million)
Table 286 Rest Of Middle East & Africa: Point Of Care Molecular Diagnostics Market, By Product & Service, 2023–2030 (Usd Million)
Table 287 Rest Of Middle East & Africa: Point Of Care Molecular Diagnostics Market, By Technology, 2023–2030 (Usd Million)
Table 288 Rest Of Middle East & Africa: Point Of Care Molecular Diagnostics Market, By Sample Type, 2023–2030 (Usd Million)
Table 289 Rest Of Middle East & Africa: Point Of Care Molecular Diagnostics Market, By Application, 2023–2030 (Usd Million)
Table 290 Rest Of Middle East & Africa: Point Of Care Molecular Diagnostics Market, By End User, 2023–2030 (Usd Million)
Table 291 Overview Of Strategies Deployed By Key Companies In Point Of Care Molecular Diagnostics Market, January 2021−july 2025
Table 292 Point Of Care Molecular Diagnostics Market: Degree Of Competition
Table 293 Point Of Care Molecular Diagnostics Market: Region Footprint
Table 294 Point Of Care Molecular Diagnostics Market: Product & Service Footprint
Table 295 Point Of Care Molecular Diagnostics Market: Technology Footprint
Table 296 Point Of Care Molecular Diagnostics Market: Application Footprint
Table 297 Point Of Care Molecular Diagnostics Market: Detailed List Of Key Startups/Smes
Table 298 Point Of Care Molecular Diagnostics Market: Competitive Benchmarking Of Key Emerging Players/Startups (1/2)
Table 299 Point Of Care Molecular Diagnostics Market: Competitive Benchmarking Of Startups/Smes (2/2)
Table 300 Point Of Care Molecular Diagnostics Market: Product/Service Launches & Approvals, January 2021–july 2025
Table 301 Point Of Care Molecular Diagnostics Market: Deals,
January 2021–july 2025
Table 302 Point Of Care Molecular Diagnostics Market: Expansions, January 2021–july 2025
Table 303 Danaher Corporation: Company Overview
Table 304 Danaher Corporation: Products/Services Offered
Table 305 Danaher Corporation: Product/Service Launches & Approvals, January 2021–july 2025
Table 306 Danaher Corporation: Deals, January 2021–july 2025
Table 307 Danaher Corporation: Expansions, January 2021–july 2025
Table 308 Biomérieux: Company Overview
Table 309 Biomérieux: Products/Services Offered
Table 310 Biomérieux: Product/Service Approvals, January 2021–july 2025
Table 311 Biomérieux: Deals, January 2021–july 2025
Table 312 F. Hoffmann-la Roche Ltd: Company Overview
Table 313 F. Hoffmann-la Roche Ltd.: Products/Services Offered
Table 314 F. Hoffmann-la Roche Ltd.: Products/Services Launches &
Approvals, January 2021–july 2025
Table 315 F. Hoffmann-la Roche Ltd.: Deals, January 2021–july 2025
Table 316 F. Hoffmann-la Roche Ltd.: Expansions, January 2021–july 2025
Table 317 Abbott: Company Overview
Table 318 Abbott Products/Services Offered
Table 319 Abbott: Deals, January 2021–july 2025
Table 320 Qiagen N.V.: Company Overview
Table 321 Qiagen N.V.: Products/Services Offered
Table 322 Qiagen N.V.: Product Launches & Approvals, January 2021–july 2025
Table 323 Qiagen N.V.: Deals, January 2021–july 2025
Table 324 Qiagen N.V.: Expansions, January 2021–july 2025
Table 325 Quidelortho Corporation: Company Overview
Table 326 Quidelortho Corporation: Products/Services Offered
Table 327 Quidelortho Corporation: Product/Service Launches & Approvals, January 2021–july 2025
Table 328 Quidelortho Corporation: Deals, January 2021–july 2025
Table 329 Quidelortho Corporation: Expansions, January 2021–july 2025
Table 330 Co-diagnostics, Inc.: Company Overview
Table 331 Co-diagnostics, Inc.: Products/Services Offered
Table 332 Co-diagnostics, Inc.: Deals, January 2021–july 2025
Table 333 Co-diagnostics, Inc.: Expansions, January 2021–july 2025
Table 334 Biocartis: Company Overview
Table 335 Biocartis: Products/Services Offered
Table 336 Biocartis: Product/Service Launches & Approvals,
January 2021–july 2025
Table 337 Biocartis: Deals, January 2021–july 2025
Table 338 Sd Biosensor, Inc.: Business Overview
Table 339 Sd Biosensor, Inc.: Products/Services Offered
Table 340 Sd Biosensor, Inc.: Product/Service Launches, January 2021–july 2025
Table 341 Sd Biosensor, Inc.: Deals, January 2021–july 2025
Table 342 Sd Biosensor, Inc.: Other Developments, January 2021–july 2025
Table 343 Genedrive Plc: Company Overview
Table 344 Genedrive Plc: Products/Services Offered
Table 345 Binx Health, Inc.: Company Overview
Table 346 Molbio Diagnostics Limited: Company Overview
Table 347 Opgen, Inc.: Company Overview
Table 348 Genomadix: Company Overview
Table 349 Visby Medical, Inc.: Company Overview
Table 350 Quantumdx Group Ltd.: Company Overview
Table 351 Detectachem: Company Overview
Table 352 Labsystems Diagnostics Oy: Company Overview
Table 353 Akonni Biosystems, Inc.: Company Overview
Table 354 Ubiquitome Limited: Company Overview
Table 355 Credo Diagnostics Biomedical Pte. Ltd.: Company Overview
Table 356 Nuclein, Llc: Company Overview
Table 357 Genes2me: Company Overview
Table 358 Axxin: Company Overview
Table 359 Huwel Lifesciences: Company Overview
Figures List
Figure 1 Point Of Care Molecular Diagnostics Market
Segmentation & Regional Scope
Figure 2 Years Considered
Figure 3 Point Of Care Molecular Diagnostics Market: Research Design Methodology
Figure 4 Primary Sources
Figure 5 Breakdown Of Primary Interviews: Supply Side And Demand Side Participants
Figure 6 Breakdown Of Primary Interviews: By Company Type,
Designation, And Region
Figure 7 Bottom-up Approach: Company Revenue Estimation Approach
Figure 8 Cagr Projections: Supply-side Analysis
Figure 9 Point Of Care Molecular Diagnostics Market: Top-down Approach
Figure 10 Data Triangulation Methodology
Figure 11 Point Of Care Molecular Diagnostics Market: Research Assumptions
Figure 12 Point Of Care Molecular Diagnostics Market, By Product & Service, 2025 Vs. 2030 (Usd Million)
Figure 13 Point Of Care Molecular Diagnostics Market, By Technology,
2025 Vs. 2030 (Usd Million)
Figure 14 Point Of Care Molecular Diagnostics Market, By Sample Type,
2025 Vs. 2030 (Usd Million)
Figure 15 Point Of Care Molecular Diagnostics Market, By Application,
2025 Vs. 2030 (Usd Million)
Figure 16 Point Of Care Molecular Diagnostics Market, By End User,
2025 Vs. 2030 (Usd Million)
Figure 17 Point Of Care Molecular Diagnostics Market, By Region,
2025 Vs. 2030 (Usd Million)
Figure 18 Increasing Advancements In Molecular Diagnostics
Technologies To Propel Market
Figure 19 Assays & Kits Segment To Dominate Market During Forecast Period
Figure 20 Rt-pcr Segment To Dominate Market During Forecast Period
Figure 21 Other Sample Types Segment To Dominate Market
During Forecast Period
Figure 22 Respiratory Diseases Segment To Dominate Market
During Forecast Period
Figure 23 Hospitals Segment To Dominate Market During Forecast Period
Figure 24 Asia Pacific Region To Grow At Highest Cagr During Forecast Period
Figure 25 Point Of Care Molecular Diagnostics Market: Drivers, Restraints, Opportunities, And Challenges
Figure 26 Patent Analysis For Point Of Care Molecular Diagnostics
(January 2014–december 2024)
Figure 27 Value Chain Analysis Of Point Of Care Molecular Diagnostics Market: Major Value Added During Manufacturing & Assembly Phases
Figure 28 Point Of Care Molecular Diagnostics Market: Supply Chain Analysis
Figure 29 Point Of Care Molecular Diagnostics Market: Ecosystem Analysis
Figure 30 Point Of Care Molecular Diagnostics Market:
Porter’s Five Forces Analysis
Figure 31 Point Of Care Molecular Diagnostics Market:
Trends & Disruptions Impacting Customers’ Businesses
Figure 32 Influence Of Stakeholders On Buying Process Of Point Of Care Molecular Diagnostic Products
Figure 33 Key Buying Criteria For Point Of Care Molecular Diagnostic Products
Figure 34 Number Of Deals & Funding Activities In Point Of Care Molecular Diagnostics Market
Figure 35 Market Potential Of Ai In Point Of Care Molecular Diagnostics Market
Figure 36 North America: Point Of Care Molecular Diagnostics Market Snapshot
Figure 37 Asia Pacific: Point Of Care Molecular Diagnostics Market Snapshot
Figure 38 Revenue Analysis Of Key Players In Point Of Care Molecular Diagnostics Market, 2022–2024
Figure 39 Market Share Analysis Of Key Players In Point Of Care Molecular Diagnostics Market (2024)
Figure 40 Point Of Care Molecular Diagnostics Market: Company Evaluation Matrix (Key Players), 2024
Figure 41 Point Of Care Molecular Diagnostics Market: Company Footprint
Figure 42 Point Of Care Molecular Diagnostics Market:
Company Evaluation Matrix (Startups/Smes), 2024
Figure 43 Ev/Ebitda Of Key Vendors
Figure 44 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta
Of Key Vendors
Figure 45 Point Of Care Molecular Diagnostics Market: Brand Comparison For Instruments
Figure 46 Danaher Corporation: Company Snapshot (2024)
Figure 47 Biomérieux: Company Snapshot (2024)
Figure 48 F. Hoffmann-la Roche Ltd.: Company Snapshot (2024)
Figure 49 Abbott: Company Snapshot (2024)
Figure 50 Qiagen N.V.: Company Snapshot (2024)
Figure 51 Quidelortho Corporation: Company Snapshot (2024)
Figure 52 Co-diagnostics, Inc.: Company Snapshot (2024)
Figure 53 Biocartis: Company Snapshot (2022)
Figure 54 Sd Biosensor, Inc.: Company Snapshot (2024)
Figure 55 Genedrive Plc: Company Snapshot (2024)

Table of Contents

328 Pages
    • STUDY OBJECTIVES
    • MARKET DEFINITION
    • STUDY SCOPE
    • KEY STAKEHOLDERS
    • SUMMARY OF CHANGES
    • RESEARCH DATA
    • RESEARCH APPROACH
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN & DATA TRIANGULATION
    • MARKET SHARE ASSESSMENT
    • RESEARCH ASSUMPTIONS
    • RESEARCH LIMITATIONS
    • RISK ASSESSMENT
  • EXECUTIVE SUMMARY
    • POINT OF CARE MOLECULAR DIAGNOSTICS MARKET OVERVIEW
    • POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION)
    • POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
    • POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION)
    • POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
    • POINT OF CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
    • POINT OF CARE MOLECULAR DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • INTRODUCTION
    • MARKET DYNAMICS
    • PRICING ANALYSIS
    • PATENT ANALYSIS
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • TRADE ANALYSIS
    • ECOSYSTEM ANALYSIS
    • PORTER'S FIVE FORCES ANALYSIS
    • REGULATORY LANDSCAPE
    • TECHNOLOGY ANALYSIS
    • KEY CONFERENCES & EVENTS, 2025-2026
    • TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • KEY STAKEHOLDERS & BUYING CRITERIA
    • INVESTMENT & FUNDING SCENARIO
    • CASE STUDY ANALYSIS
    • IMPACT OF AI/GENERATIVE AI IN POINT OF CARE MOLECULAR DIAGNOSTICS MARKET
    • TRUMP TARIFF IMPACT ON POINT OF CARE MOLECULAR DIAGNOSTICS MARKET
    • INTRODUCTION
    • ASSAYS & KITS
    • INSTRUMENTS & ANALYZERS
    • SOFTWARE & SERVICES
    • INTRODUCTION
    • RT-PCR
    • INAAT
    • OTHER TECHNOLOGIES
    • INTRODUCTION
    • BLOOD SAMPLES
    • URINE SAMPLES
    • OTHER SAMPLE TYPES
    • INTRODUCTION
    • RESPIRATORY DISEASES
    • SEXUALLY TRANSMITTED DISEASES
    • HOSPITAL-ACQUIRED INFECTIONS
    • CANCER
    • HEPATITIS
    • GASTROINTESTINAL DISORDERS
    • OTHER APPLICATIONS
    • INTRODUCTION
    • HOSPITALS
    • PHYSICIANS' OFFICES/CLINICS
    • RESEARCH INSTITUTES
    • OTHER END USERS
    • INTRODUCTION
    • NORTH AMERICA
    • EUROPE
    • ASIA PACIFIC
    • LATIN AMERICA
    • MIDDLE EAST & AFRICA
    • INTRODUCTION
    • KEY PLAYER STRATEGIES/RIGHT TO WIN
    • REVENUE SHARE ANALYSIS, 2022-2024
    • MARKET SHARE ANALYSIS, 2024
    • COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • COMPANY VALUATION & FINANCIAL METRICS
    • BRAND/PRODUCT COMPARISON
    • COMPETITIVE SCENARIO
    • KEY PLAYERS
    • OTHER PLAYERS
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.